Marathon Petroleum vs ExxonMobil
MPC and XOM side by side, both in petroleum refining. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MPC and XOM compare
ExxonMobil is the larger company, worth 6.2 times as much as Marathon Petroleum ($770B against $125B).
On earnings, Marathon Petroleum is cheaper: it trades at 15.3× trailing earnings, against 24.1× for ExxonMobil.
Marathon Petroleum grew revenue faster over the last twelve months (15.0% versus 9.1% for ExxonMobil).
ExxonMobil keeps more of each dollar of sales as profit, with a net margin of 8.9% compared with 5.6% at Marathon Petroleum.
Both pay dividends: Marathon Petroleum yields 0.90% and ExxonMobil 2.2%.
Marathon Petroleum scores higher on the StockData Score (16 against 11 for ExxonMobil), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MPC | XOM |
|---|---|---|
| Size and price | ||
| Market cap | $125B | $770B |
| Share price | $444.73 | $187.25 |
| Change, 1 year | 127% | 60.8% |
| Change, 5 years | 576% | 188% |
| Beta (5Y) | 0.51 | 0.27 |
| Employees | 19K | 58K |
| StockData Score | ||
| Total score | 16 (better) | 11 |
| Valuation score | 1 | 1 |
| Growth score | 3 (better) | 0 |
| Performance score | 4 (better) | 1 |
| Health score | 4 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 15.3× (better) | 24.1× |
| P/S | 0.8× (better) | 2.1× |
| P/B | 6.5× | 3.0× (better) |
| EV/EBITDA | 9.0× (better) | 10.7× |
| P/FCF | 9.7× (better) | 25.2× |
| FCF yield | 10.3% (better) | 4.0% |
| Fair value | $413.58 | $134.59 |
| Margin of safety | −7.5% (better) | −39.1% |
| Growth | ||
| Revenue growth (TTM) | 15.0% (better) | 9.1% |
| Revenue growth, 5Y average | 13.7% (better) | 12.9% |
| Net income growth (TTM) | 301% (better) | 5.6% |
| EPS growth (TTM) | 331% (better) | 10.4% |
| Profitability | ||
| Gross margin | 12.5% | – |
| Operating margin | 9.2% | – |
| Net margin | 5.6% | 8.9% (better) |
| FCF margin | 8.4% (better) | 8.3% |
| Return on equity | 47.9% (better) | 12.6% |
| Return on invested capital | 26.0% | – |
| Financial health | ||
| Debt / equity | 1.72 | 0.16 (better) |
| Net debt / EBITDA | 1.44 | 0.42 (better) |
| Interest coverage | 8.7× | – |
| Current ratio | 1.25 (better) | 1.13 |
| Altman Z-score | 3.97 | 4.64 (better) |
| Piotroski F-score | 8 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 0.90% | 2.2% (better) |
| Payout ratio | 13.6% | 52.6% |
| Years of dividend growth | 4 | 16 (better) |
| Dividend growth, 5Y average | 10.0% (better) | 2.8% |
| Buyback yield | 3.9% (better) | 2.7% |
| Shareholder yield | 4.8% | 4.9% (better) |
| Ownership | ||
| Held by institutions | 78.0% | 66.0% |
| Held by insiders | 0.30% | 0.00% |
| Insider net buying, 12 months | −$13.9M | – |
| Superinvestors holding | 1 | 3 (better) |
| Short interest, % of float | 2.5% | 0.95% |
Go deeper
- MPC stock overview
- MPC income statement
- MPC valuation and score
- XOM stock overview
- XOM income statement
- XOM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.